Rivard A - Search Results

1

Early cell loss after angioplasty results in a disproportionate decrease in percutaneous gene transfer to the vessel wall.

Rivard A, Luo Z, Perlman H, Fabre JE, Nguyen T, Maillard L, Walsh K. Rivard A, et al. Hum Gene Ther. 1999 Mar 20;10(5):711-21. doi: 10.1089/10430349950018472. Hum Gene Ther. 1999. PMID: 10210139

2

Effects of poloxamer 407 on transfection time and percutaneous adenovirus-mediated gene transfer in native and stented vessels.

Van Belle E, Maillard L, Rivard A, Fabre JE, Couffinhal T, Kearney M, Branellec D, Feldman LJ, Walsh K, Isner JM. Van Belle E, et al. Among authors: rivard a. Hum Gene Ther. 1998 May 1;9(7):1013-24. doi: 10.1089/hum.1998.9.7-1013. Hum Gene Ther. 1998. PMID: 9607413

3

Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries.

Maillard L, Van Belle E, Tio FO, Rivard A, Kearney M, Branellec D, Steg PG, Isner JM, Walsh K. Maillard L, et al. Among authors: rivard a. Gene Ther. 2000 Aug;7(16):1353-61. doi: 10.1038/sj.gt.3301255. Gene Ther. 2000. PMID: 10981661

4

Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo.

Fabre JE, Rivard A, Magner M, Silver M, Isner JM. Fabre JE, et al. Among authors: rivard a. Circulation. 1999 Jun 15;99(23):3043-9. doi: 10.1161/01.cir.99.23.3043. Circulation. 1999. PMID: 10368123

5

Age-dependent impairment of angiogenesis.

Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, Magner M, Asahara T, Isner JM. Rivard A, et al. Circulation. 1999 Jan 5-12;99(1):111-20. doi: 10.1161/01.cir.99.1.111. Circulation. 1999. PMID: 9884387

6

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment.

Stewart DJ, Hilton JD, Arnold JM, Gregoire J, Rivard A, Archer SL, Charbonneau F, Cohen E, Curtis M, Buller CE, Mendelsohn FO, Dib N, Page P, Ducas J, Plante S, Sullivan J, Macko J, Rasmussen C, Kessler PD, Rasmussen HS. Stewart DJ, et al. Among authors: rivard a. Gene Ther. 2006 Nov;13(21):1503-11. doi: 10.1038/sj.gt.3302802. Epub 2006 Jun 22. Gene Ther. 2006. PMID: 16791287 Clinical Trial.

7

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM. Rivard A, et al. Am J Pathol. 1999 Feb;154(2):355-63. doi: 10.1016/S0002-9440(10)65282-0. Am J Pathol. 1999. PMID: 10027394 Free PMC article.

8

Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity.

Rivard A, Berthou-Soulie L, Principe N, Kearney M, Curry C, Branellec D, Semenza GL, Isner JM. Rivard A, et al. J Biol Chem. 2000 Sep 22;275(38):29643-7. doi: 10.1074/jbc.M001029200. J Biol Chem. 2000. PMID: 10882714 Free article.

9

Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor.

Gennaro G, Ménard C, Michaud SE, Rivard A. Gennaro G, et al. Among authors: rivard a. Circulation. 2003 Jan 21;107(2):230-3. doi: 10.1161/01.cir.0000050652.47145.4c. Circulation. 2003. PMID: 12538420

10

Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells. A potential link between aging, smooth muscle cell proliferation and atherosclerosis.

Rivard A, Principe N, Andrés V. Rivard A, et al. Cardiovasc Res. 2000 Mar;45(4):1026-34. doi: 10.1016/s0008-6363(99)00385-5. Cardiovasc Res. 2000. PMID: 10728429 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters